Michael Lawler

4PUBLICATIONS
26CO-AUTHORS
AutoimmunityMedical infection agents (incl. prions)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 20, 2025
TLR2 agonism suppresses myeloid leukemogenesis by reprogramming leukemia stem cells.

Michael E Lawler, Jennifer S Romer-Seibert, Michael S Bowman

|Nov 23, 2024
miR-196b-Oct1/2 axis regulates DNMT3A-mutant AML pathogenesis.

Michael E Lawler, Melanie L Goetz, Jennifer S Romer-Seibert

|Mar 16, 2023
S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes.

Cindy Lin, Laura Garcia-Gerique, Erin E Bonner

|Aug 09, 2022
miR-196b-TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML.

Holly A Gamlen, Jennifer S Romer-Seibert, Michael E Lawler

Pageof 1